BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8630410)

  • 21. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.
    Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM
    Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis.
    Roy V; Verfaillie CM
    Exp Hematol; 1999 Feb; 27(2):302-12. PubMed ID: 10029170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulatory effect of integrin alpha5 and beta1 on proliferation inhibition of K562 cells induced by interferon alpha-2b].
    Niu ZY; Pan L; Zhang XJ; Liu YJ
    Ai Zheng; 2006 Mar; 25(3):297-302. PubMed ID: 16536982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
    Carlo-Stella C; Regazzi E; Sammarelli G; Colla S; Garau D; Gazit A; Savoldo B; Cilloni D; Tabilio A; Levitzki A; Rizzoli V
    Blood; 1999 Jun; 93(11):3973-82. PubMed ID: 10339507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The significance of the adhesion of CD(34)(+) stem/progenitor cells to fibronectin in the pathogenesis of chronic myelogenous leukemia].
    Li Z; Li J; Fu J; Chen S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):138-40. PubMed ID: 11876973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity.
    Jiang Y; Zhao RC; Verfaillie CM
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10538-43. PubMed ID: 10973491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
    Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
    Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
    Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
    Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
    Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R
    Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
    Dilloo D; Hanenberg H; Lion T; Burdach S
    Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
    Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
    Sirard C; Lapidot T; Vormoor J; Cashman JD; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp PM; Eaves CJ; Dick JE
    Blood; 1996 Feb; 87(4):1539-48. PubMed ID: 8608245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors.
    Traycoff CM; Srour EF; Dutt P; Fan Y; Cornetta K
    Leukemia; 1997 Jan; 11(1):159-67. PubMed ID: 9001433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.
    Dylla SJ; Deyle DR; Theunissen K; Padurean AM; Verfaillie CM
    Exp Hematol; 2004 Apr; 32(4):365-74. PubMed ID: 15050747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
    Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.
    Bhatia R; McGlave PB; Verfaillie CM
    J Clin Invest; 1995 Aug; 96(2):931-9. PubMed ID: 7543495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.
    Peled A; Hardan I; Trakhtenbrot L; Gur E; Magid M; Darash-Yahana M; Cohen N; Grabovsky V; Franitza S; Kollet O; Lider O; Alon R; Rechavi G; Lapidot T
    Stem Cells; 2002; 20(3):259-66. PubMed ID: 12004084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential cation regulation of the alpha 5 beta 1 integrin-mediated adhesion of leukemic cells to the central cell-binding domain of fibronectin.
    Yin Z; Gabriele E; Leprini A; Perris R; Colombatti A
    Cell Growth Differ; 1997 Dec; 8(12):1339-47. PubMed ID: 9419422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.